Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report

BACKGROUND: Metastatic neuroendocrine carcinoma has an extremely poor prognosis, and no effective second-line treatment is available. Herein, we describe a case of multiple metastases after primary resection of esophageal neuroendocrine carcinoma successfully treated with nivolumab plus radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Kuniyasu, Kamada, Teppei, Fuse, Yoshinobu, Kai, Wataru, Takahashi, Junji, Nakashima, Keigo, Nakaseko, Yuichi, Suzuki, Norihiko, Yoshida, Masashi, Okada, Shinya, Ohdaira, Hironori, Suzuki, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486903/
https://www.ncbi.nlm.nih.gov/pubmed/34596772
http://dx.doi.org/10.1186/s40792-021-01307-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486903/
https://www.ncbi.nlm.nih.gov/pubmed/34596772
http://dx.doi.org/10.1186/s40792-021-01307-3

Ejemplares similares